nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7—Salmeterol—asthma	0.0361	0.0572	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Salmeterol—asthma	0.0361	0.0572	CbGbCtD
Nefazodone—CYP3A7—Fluticasone Propionate—asthma	0.0307	0.0487	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Fluticasone Propionate—asthma	0.0307	0.0487	CbGbCtD
Nefazodone—CYP3A5—Salmeterol—asthma	0.0271	0.0429	CbGbCtD
Nefazodone—CYP3A5—Beclomethasone—asthma	0.0271	0.0429	CbGbCtD
Nefazodone—ABCB1—Fluticasone furoate—asthma	0.0232	0.0369	CbGbCtD
Nefazodone—CYP3A5—Fluticasone Propionate—asthma	0.023	0.0365	CbGbCtD
Nefazodone—ABCB1—Indacaterol—asthma	0.0189	0.0301	CbGbCtD
Nefazodone—CYP2D6—Ciclesonide—asthma	0.0178	0.0283	CbGbCtD
Nefazodone—CYP2D6—Ipratropium bromide—asthma	0.0148	0.0235	CbGbCtD
Nefazodone—CYP3A4—Fluticasone furoate—asthma	0.0139	0.0221	CbGbCtD
Nefazodone—CYP2D6—Zafirlukast—asthma	0.013	0.0207	CbGbCtD
Nefazodone—CYP2D6—Formoterol—asthma	0.0126	0.02	CbGbCtD
Nefazodone—CYP2D6—Arformoterol—asthma	0.0126	0.02	CbGbCtD
Nefazodone—CYP3A4—Budesonide—asthma	0.0124	0.0197	CbGbCtD
Nefazodone—CYP3A7—Hydrocortisone—asthma	0.0115	0.0183	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Hydrocortisone—asthma	0.0115	0.0183	CbGbCtD
Nefazodone—CYP3A4—Ciclesonide—asthma	0.0113	0.018	CbGbCtD
Nefazodone—CYP3A4—Indacaterol—asthma	0.0113	0.018	CbGbCtD
Nefazodone—CYP2D6—Tiotropium—asthma	0.0112	0.0178	CbGbCtD
Nefazodone—CYP3A4—Salbutamol—asthma	0.0105	0.0167	CbGbCtD
Nefazodone—CYP3A4—Salmeterol—asthma	0.0105	0.0167	CbGbCtD
Nefazodone—CYP3A4—Flunisolide—asthma	0.0105	0.0167	CbGbCtD
Nefazodone—ABCB1—Loratadine—asthma	0.0101	0.0161	CbGbCtD
Nefazodone—CYP2D6—Theophylline—asthma	0.0101	0.016	CbGbCtD
Nefazodone—CYP2D6—Loratadine—asthma	0.00953	0.0151	CbGbCtD
Nefazodone—CYP3A4—Ipratropium bromide—asthma	0.0094	0.0149	CbGbCtD
Nefazodone—CYP3A4—Zileuton—asthma	0.0094	0.0149	CbGbCtD
Nefazodone—ABCB1—Methylprednisolone—asthma	0.00925	0.0147	CbGbCtD
Nefazodone—CYP3A4—Fluticasone Propionate—asthma	0.00897	0.0142	CbGbCtD
Nefazodone—CYP3A5—Hydrocortisone—asthma	0.00864	0.0137	CbGbCtD
Nefazodone—CYP3A4—Zafirlukast—asthma	0.00828	0.0131	CbGbCtD
Nefazodone—CYP3A7—Dexamethasone—asthma	0.00716	0.0114	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dexamethasone—asthma	0.00716	0.0114	CbGbCtD
Nefazodone—CYP3A4—Tiotropium—asthma	0.00713	0.0113	CbGbCtD
Nefazodone—CYP3A4—Aminophylline—asthma	0.0068	0.0108	CbGbCtD
Nefazodone—CYP3A4—Theophylline—asthma	0.00639	0.0101	CbGbCtD
Nefazodone—CYP3A4—Montelukast—asthma	0.00606	0.00962	CbGbCtD
Nefazodone—CYP3A4—Loratadine—asthma	0.00606	0.00962	CbGbCtD
Nefazodone—ABCB1—Betamethasone—asthma	0.00601	0.00955	CbGbCtD
Nefazodone—ABCB1—Prednisolone—asthma	0.00593	0.00942	CbGbCtD
Nefazodone—ABCB1—Hydrocortisone—asthma	0.00562	0.00893	CbGbCtD
Nefazodone—ABCB1—Prednisone—asthma	0.0056	0.0089	CbGbCtD
Nefazodone—CYP3A4—Methylprednisolone—asthma	0.00554	0.0088	CbGbCtD
Nefazodone—CYP3A5—Dexamethasone—asthma	0.00537	0.00853	CbGbCtD
Nefazodone—CYP3A4—Triamcinolone—asthma	0.0042	0.00667	CbGbCtD
Nefazodone—CYP3A4—Betamethasone—asthma	0.0036	0.00572	CbGbCtD
Nefazodone—CYP3A4—Prednisolone—asthma	0.00355	0.00564	CbGbCtD
Nefazodone—ABCB1—Dexamethasone—asthma	0.0035	0.00555	CbGbCtD
Nefazodone—CYP3A4—Hydrocortisone—asthma	0.00337	0.00535	CbGbCtD
Nefazodone—CYP3A4—Prednisone—asthma	0.00336	0.00533	CbGbCtD
Nefazodone—CYP2D6—Dexamethasone—asthma	0.0033	0.00523	CbGbCtD
Nefazodone—SLC6A2—autonomic nervous system—asthma	0.00213	0.143	CbGeAlD
Nefazodone—CYP3A4—Dexamethasone—asthma	0.0021	0.00333	CbGbCtD
Nefazodone—HTR2A—vagus nerve—asthma	0.00184	0.124	CbGeAlD
Nefazodone—HTR2A—autonomic nervous system—asthma	0.00128	0.0862	CbGeAlD
Nefazodone—SLC6A3—respiratory system—asthma	0.000679	0.0457	CbGeAlD
Nefazodone—SLC6A4—respiratory system—asthma	0.000622	0.0419	CbGeAlD
Nefazodone—SLC6A2—respiratory system—asthma	0.000548	0.0369	CbGeAlD
Nefazodone—ADRA1A—epithelium—asthma	0.000426	0.0287	CbGeAlD
Nefazodone—HTR1A—cardiovascular system—asthma	0.000423	0.0285	CbGeAlD
Nefazodone—CYP3A5—respiratory system—asthma	0.000406	0.0273	CbGeAlD
Nefazodone—ADRA1A—cardiovascular system—asthma	0.00039	0.0263	CbGeAlD
Nefazodone—SLC6A3—lung—asthma	0.00036	0.0243	CbGeAlD
Nefazodone—HTR1A—adrenal gland—asthma	0.000335	0.0225	CbGeAlD
Nefazodone—SLC6A2—adrenal gland—asthma	0.000332	0.0223	CbGeAlD
Nefazodone—SLC6A4—lung—asthma	0.00033	0.0222	CbGeAlD
Nefazodone—HTR2A—respiratory system—asthma	0.000329	0.0222	CbGeAlD
Nefazodone—ADRA2A—bronchus—asthma	0.000319	0.0215	CbGeAlD
Nefazodone—ADRA1A—adrenal gland—asthma	0.000308	0.0208	CbGeAlD
Nefazodone—SLC6A2—lung—asthma	0.000291	0.0196	CbGeAlD
Nefazodone—ADRA2A—trachea—asthma	0.000286	0.0193	CbGeAlD
Nefazodone—HTR2A—epithelium—asthma	0.000275	0.0185	CbGeAlD
Nefazodone—HTR2A—smooth muscle tissue—asthma	0.000265	0.0179	CbGeAlD
Nefazodone—HTR2A—cardiovascular system—asthma	0.000252	0.017	CbGeAlD
Nefazodone—HTR2A—trachea—asthma	0.000243	0.0164	CbGeAlD
Nefazodone—ADRA2A—adrenal gland—asthma	0.000235	0.0158	CbGeAlD
Nefazodone—ABCB1—respiratory system—asthma	0.000216	0.0145	CbGeAlD
Nefazodone—CYP3A5—lung—asthma	0.000216	0.0145	CbGeAlD
Nefazodone—ADRA2A—lung—asthma	0.000206	0.0138	CbGeAlD
Nefazodone—HTR2A—adrenal gland—asthma	0.000199	0.0134	CbGeAlD
Nefazodone—ABCB1—adrenal cortex—asthma	0.000181	0.0122	CbGeAlD
Nefazodone—ABCB1—epithelium—asthma	0.00018	0.0121	CbGeAlD
Nefazodone—HTR2A—lung—asthma	0.000175	0.0118	CbGeAlD
Nefazodone—ABCB1—cardiovascular system—asthma	0.000165	0.0111	CbGeAlD
Nefazodone—ABCB1—trachea—asthma	0.000159	0.0107	CbGeAlD
Nefazodone—ABCB1—adrenal gland—asthma	0.000131	0.0088	CbGeAlD
Nefazodone—ABCB1—lung—asthma	0.000115	0.00771	CbGeAlD
Nefazodone—Hypertension—Hydrocortisone—asthma	4.58e-05	0.000177	CcSEcCtD
Nefazodone—Discomfort—Prednisolone—asthma	4.57e-05	0.000176	CcSEcCtD
Nefazodone—Angioedema—Triamcinolone—asthma	4.56e-05	0.000176	CcSEcCtD
Nefazodone—Haemoglobin—Prednisone—asthma	4.56e-05	0.000176	CcSEcCtD
Nefazodone—Angioedema—Methylprednisolone—asthma	4.55e-05	0.000176	CcSEcCtD
Nefazodone—Haemorrhage—Prednisone—asthma	4.53e-05	0.000175	CcSEcCtD
Nefazodone—Myalgia—Hydrocortisone—asthma	4.51e-05	0.000174	CcSEcCtD
Nefazodone—Hallucination—Prednisone—asthma	4.51e-05	0.000174	CcSEcCtD
Nefazodone—Malaise—Triamcinolone—asthma	4.5e-05	0.000174	CcSEcCtD
Nefazodone—Anxiety—Hydrocortisone—asthma	4.5e-05	0.000173	CcSEcCtD
Nefazodone—Malaise—Methylprednisolone—asthma	4.49e-05	0.000173	CcSEcCtD
Nefazodone—Vertigo—Triamcinolone—asthma	4.49e-05	0.000173	CcSEcCtD
Nefazodone—Syncope—Triamcinolone—asthma	4.48e-05	0.000173	CcSEcCtD
Nefazodone—Vertigo—Methylprednisolone—asthma	4.48e-05	0.000173	CcSEcCtD
Nefazodone—Syncope—Methylprednisolone—asthma	4.47e-05	0.000172	CcSEcCtD
Nefazodone—Discomfort—Hydrocortisone—asthma	4.46e-05	0.000172	CcSEcCtD
Nefazodone—Nausea—Budesonide—asthma	4.45e-05	0.000171	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisolone—asthma	4.43e-05	0.000171	CcSEcCtD
Nefazodone—Oedema—Prednisolone—asthma	4.43e-05	0.000171	CcSEcCtD
Nefazodone—Loss of consciousness—Triamcinolone—asthma	4.39e-05	0.000169	CcSEcCtD
Nefazodone—Loss of consciousness—Methylprednisolone—asthma	4.38e-05	0.000169	CcSEcCtD
Nefazodone—Shock—Prednisolone—asthma	4.36e-05	0.000168	CcSEcCtD
Nefazodone—Cough—Triamcinolone—asthma	4.36e-05	0.000168	CcSEcCtD
Nefazodone—Oedema—Hydrocortisone—asthma	4.33e-05	0.000167	CcSEcCtD
Nefazodone—Anaphylactic shock—Hydrocortisone—asthma	4.33e-05	0.000167	CcSEcCtD
Nefazodone—Convulsion—Triamcinolone—asthma	4.33e-05	0.000167	CcSEcCtD
Nefazodone—Tachycardia—Prednisolone—asthma	4.33e-05	0.000167	CcSEcCtD
Nefazodone—Convulsion—Methylprednisolone—asthma	4.32e-05	0.000166	CcSEcCtD
Nefazodone—Hypertension—Triamcinolone—asthma	4.31e-05	0.000166	CcSEcCtD
Nefazodone—Hypertension—Methylprednisolone—asthma	4.3e-05	0.000166	CcSEcCtD
Nefazodone—Infection—Hydrocortisone—asthma	4.3e-05	0.000166	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisolone—asthma	4.28e-05	0.000165	CcSEcCtD
Nefazodone—Shock—Hydrocortisone—asthma	4.26e-05	0.000164	CcSEcCtD
Nefazodone—Myalgia—Triamcinolone—asthma	4.25e-05	0.000164	CcSEcCtD
Nefazodone—Arthralgia—Methylprednisolone—asthma	4.24e-05	0.000164	CcSEcCtD
Nefazodone—Myalgia—Methylprednisolone—asthma	4.24e-05	0.000164	CcSEcCtD
Nefazodone—Anxiety—Methylprednisolone—asthma	4.23e-05	0.000163	CcSEcCtD
Nefazodone—Tachycardia—Hydrocortisone—asthma	4.22e-05	0.000163	CcSEcCtD
Nefazodone—Flushing—Prednisone—asthma	4.21e-05	0.000162	CcSEcCtD
Nefazodone—Ill-defined disorder—Betamethasone—asthma	4.2e-05	0.000162	CcSEcCtD
Nefazodone—Ill-defined disorder—Dexamethasone—asthma	4.2e-05	0.000162	CcSEcCtD
Nefazodone—Discomfort—Triamcinolone—asthma	4.2e-05	0.000162	CcSEcCtD
Nefazodone—Discomfort—Methylprednisolone—asthma	4.19e-05	0.000162	CcSEcCtD
Nefazodone—Hyperhidrosis—Hydrocortisone—asthma	4.18e-05	0.000161	CcSEcCtD
Nefazodone—Dry mouth—Triamcinolone—asthma	4.16e-05	0.00016	CcSEcCtD
Nefazodone—Angioedema—Betamethasone—asthma	4.14e-05	0.00016	CcSEcCtD
Nefazodone—Angioedema—Dexamethasone—asthma	4.14e-05	0.00016	CcSEcCtD
Nefazodone—Anorexia—Hydrocortisone—asthma	4.13e-05	0.000159	CcSEcCtD
Nefazodone—Confusional state—Methylprednisolone—asthma	4.1e-05	0.000158	CcSEcCtD
Nefazodone—Malaise—Dexamethasone—asthma	4.09e-05	0.000158	CcSEcCtD
Nefazodone—Malaise—Betamethasone—asthma	4.09e-05	0.000158	CcSEcCtD
Nefazodone—Oedema—Triamcinolone—asthma	4.08e-05	0.000157	CcSEcCtD
Nefazodone—Anaphylactic shock—Triamcinolone—asthma	4.08e-05	0.000157	CcSEcCtD
Nefazodone—Vertigo—Betamethasone—asthma	4.07e-05	0.000157	CcSEcCtD
Nefazodone—Vertigo—Dexamethasone—asthma	4.07e-05	0.000157	CcSEcCtD
Nefazodone—Anaphylactic shock—Methylprednisolone—asthma	4.07e-05	0.000157	CcSEcCtD
Nefazodone—Syncope—Dexamethasone—asthma	4.06e-05	0.000157	CcSEcCtD
Nefazodone—Syncope—Betamethasone—asthma	4.06e-05	0.000157	CcSEcCtD
Nefazodone—Infection—Triamcinolone—asthma	4.05e-05	0.000156	CcSEcCtD
Nefazodone—Hypotension—Hydrocortisone—asthma	4.04e-05	0.000156	CcSEcCtD
Nefazodone—Infection—Methylprednisolone—asthma	4.04e-05	0.000156	CcSEcCtD
Nefazodone—Shock—Triamcinolone—asthma	4.01e-05	0.000155	CcSEcCtD
Nefazodone—Insomnia—Prednisolone—asthma	4.01e-05	0.000155	CcSEcCtD
Nefazodone—Alopecia—Prednisone—asthma	4.01e-05	0.000154	CcSEcCtD
Nefazodone—Shock—Methylprednisolone—asthma	4e-05	0.000154	CcSEcCtD
Nefazodone—Loss of consciousness—Betamethasone—asthma	3.98e-05	0.000154	CcSEcCtD
Nefazodone—Loss of consciousness—Dexamethasone—asthma	3.98e-05	0.000154	CcSEcCtD
Nefazodone—Paraesthesia—Prednisolone—asthma	3.98e-05	0.000153	CcSEcCtD
Nefazodone—Tachycardia—Triamcinolone—asthma	3.98e-05	0.000153	CcSEcCtD
Nefazodone—Tachycardia—Methylprednisolone—asthma	3.97e-05	0.000153	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Hydrocortisone—asthma	3.94e-05	0.000152	CcSEcCtD
Nefazodone—Hyperhidrosis—Triamcinolone—asthma	3.94e-05	0.000152	CcSEcCtD
Nefazodone—Hyperhidrosis—Methylprednisolone—asthma	3.93e-05	0.000152	CcSEcCtD
Nefazodone—Convulsion—Betamethasone—asthma	3.93e-05	0.000151	CcSEcCtD
Nefazodone—Convulsion—Dexamethasone—asthma	3.93e-05	0.000151	CcSEcCtD
Nefazodone—Insomnia—Hydrocortisone—asthma	3.91e-05	0.000151	CcSEcCtD
Nefazodone—Hypertension—Betamethasone—asthma	3.91e-05	0.000151	CcSEcCtD
Nefazodone—Hypertension—Dexamethasone—asthma	3.91e-05	0.000151	CcSEcCtD
Nefazodone—Paraesthesia—Hydrocortisone—asthma	3.89e-05	0.00015	CcSEcCtD
Nefazodone—Myalgia—Betamethasone—asthma	3.86e-05	0.000149	CcSEcCtD
Nefazodone—Myalgia—Dexamethasone—asthma	3.86e-05	0.000149	CcSEcCtD
Nefazodone—Anxiety—Dexamethasone—asthma	3.84e-05	0.000148	CcSEcCtD
Nefazodone—Anxiety—Betamethasone—asthma	3.84e-05	0.000148	CcSEcCtD
Nefazodone—Discomfort—Dexamethasone—asthma	3.81e-05	0.000147	CcSEcCtD
Nefazodone—Discomfort—Betamethasone—asthma	3.81e-05	0.000147	CcSEcCtD
Nefazodone—Dyspepsia—Hydrocortisone—asthma	3.81e-05	0.000147	CcSEcCtD
Nefazodone—Hypotension—Methylprednisolone—asthma	3.8e-05	0.000146	CcSEcCtD
Nefazodone—Pain—Prednisolone—asthma	3.79e-05	0.000146	CcSEcCtD
Nefazodone—Decreased appetite—Hydrocortisone—asthma	3.76e-05	0.000145	CcSEcCtD
Nefazodone—Vision blurred—Prednisone—asthma	3.72e-05	0.000143	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Triamcinolone—asthma	3.71e-05	0.000143	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methylprednisolone—asthma	3.7e-05	0.000143	CcSEcCtD
Nefazodone—Pain—Hydrocortisone—asthma	3.7e-05	0.000143	CcSEcCtD
Nefazodone—Oedema—Dexamethasone—asthma	3.7e-05	0.000143	CcSEcCtD
Nefazodone—Anaphylactic shock—Dexamethasone—asthma	3.7e-05	0.000143	CcSEcCtD
Nefazodone—Anaphylactic shock—Betamethasone—asthma	3.7e-05	0.000143	CcSEcCtD
Nefazodone—Oedema—Betamethasone—asthma	3.7e-05	0.000143	CcSEcCtD
Nefazodone—Insomnia—Triamcinolone—asthma	3.69e-05	0.000142	CcSEcCtD
Nefazodone—Insomnia—Methylprednisolone—asthma	3.68e-05	0.000142	CcSEcCtD
Nefazodone—Infection—Betamethasone—asthma	3.67e-05	0.000142	CcSEcCtD
Nefazodone—Infection—Dexamethasone—asthma	3.67e-05	0.000142	CcSEcCtD
Nefazodone—Ill-defined disorder—Prednisone—asthma	3.66e-05	0.000141	CcSEcCtD
Nefazodone—Paraesthesia—Triamcinolone—asthma	3.66e-05	0.000141	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisolone—asthma	3.65e-05	0.000141	CcSEcCtD
Nefazodone—Paraesthesia—Methylprednisolone—asthma	3.65e-05	0.000141	CcSEcCtD
Nefazodone—Anaemia—Prednisone—asthma	3.65e-05	0.000141	CcSEcCtD
Nefazodone—Shock—Betamethasone—asthma	3.64e-05	0.00014	CcSEcCtD
Nefazodone—Shock—Dexamethasone—asthma	3.64e-05	0.00014	CcSEcCtD
Nefazodone—Dyspnoea—Triamcinolone—asthma	3.63e-05	0.00014	CcSEcCtD
Nefazodone—Agitation—Prednisone—asthma	3.63e-05	0.00014	CcSEcCtD
Nefazodone—Thrombocytopenia—Dexamethasone—asthma	3.62e-05	0.00014	CcSEcCtD
Nefazodone—Thrombocytopenia—Betamethasone—asthma	3.62e-05	0.00014	CcSEcCtD
Nefazodone—Tachycardia—Dexamethasone—asthma	3.61e-05	0.000139	CcSEcCtD
Nefazodone—Tachycardia—Betamethasone—asthma	3.61e-05	0.000139	CcSEcCtD
Nefazodone—Angioedema—Prednisone—asthma	3.61e-05	0.000139	CcSEcCtD
Nefazodone—Dyspepsia—Triamcinolone—asthma	3.59e-05	0.000138	CcSEcCtD
Nefazodone—Dyspepsia—Methylprednisolone—asthma	3.58e-05	0.000138	CcSEcCtD
Nefazodone—Hyperhidrosis—Dexamethasone—asthma	3.57e-05	0.000138	CcSEcCtD
Nefazodone—Hyperhidrosis—Betamethasone—asthma	3.57e-05	0.000138	CcSEcCtD
Nefazodone—Feeling abnormal—Hydrocortisone—asthma	3.57e-05	0.000137	CcSEcCtD
Nefazodone—Malaise—Prednisone—asthma	3.56e-05	0.000137	CcSEcCtD
Nefazodone—Vertigo—Prednisone—asthma	3.55e-05	0.000137	CcSEcCtD
Nefazodone—Gastrointestinal pain—Hydrocortisone—asthma	3.54e-05	0.000136	CcSEcCtD
Nefazodone—Syncope—Prednisone—asthma	3.54e-05	0.000136	CcSEcCtD
Nefazodone—Anorexia—Betamethasone—asthma	3.52e-05	0.000136	CcSEcCtD
Nefazodone—Anorexia—Dexamethasone—asthma	3.52e-05	0.000136	CcSEcCtD
Nefazodone—Urticaria—Prednisolone—asthma	3.52e-05	0.000136	CcSEcCtD
Nefazodone—Pain—Triamcinolone—asthma	3.48e-05	0.000134	CcSEcCtD
Nefazodone—Loss of consciousness—Prednisone—asthma	3.47e-05	0.000134	CcSEcCtD
Nefazodone—Hypotension—Betamethasone—asthma	3.46e-05	0.000133	CcSEcCtD
Nefazodone—Hypotension—Dexamethasone—asthma	3.46e-05	0.000133	CcSEcCtD
Nefazodone—Urticaria—Hydrocortisone—asthma	3.44e-05	0.000133	CcSEcCtD
Nefazodone—Body temperature increased—Hydrocortisone—asthma	3.42e-05	0.000132	CcSEcCtD
Nefazodone—Abdominal pain—Hydrocortisone—asthma	3.42e-05	0.000132	CcSEcCtD
Nefazodone—Convulsion—Prednisone—asthma	3.42e-05	0.000132	CcSEcCtD
Nefazodone—Hypertension—Prednisone—asthma	3.41e-05	0.000131	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betamethasone—asthma	3.37e-05	0.00013	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Dexamethasone—asthma	3.37e-05	0.00013	CcSEcCtD
Nefazodone—Arthralgia—Prednisone—asthma	3.36e-05	0.00013	CcSEcCtD
Nefazodone—Myalgia—Prednisone—asthma	3.36e-05	0.00013	CcSEcCtD
Nefazodone—Feeling abnormal—Triamcinolone—asthma	3.36e-05	0.000129	CcSEcCtD
Nefazodone—Feeling abnormal—Methylprednisolone—asthma	3.35e-05	0.000129	CcSEcCtD
Nefazodone—Anxiety—Prednisone—asthma	3.35e-05	0.000129	CcSEcCtD
Nefazodone—Insomnia—Dexamethasone—asthma	3.34e-05	0.000129	CcSEcCtD
Nefazodone—Insomnia—Betamethasone—asthma	3.34e-05	0.000129	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methylprednisolone—asthma	3.33e-05	0.000128	CcSEcCtD
Nefazodone—Paraesthesia—Dexamethasone—asthma	3.32e-05	0.000128	CcSEcCtD
Nefazodone—Paraesthesia—Betamethasone—asthma	3.32e-05	0.000128	CcSEcCtD
Nefazodone—Discomfort—Prednisone—asthma	3.32e-05	0.000128	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisolone—asthma	3.26e-05	0.000126	CcSEcCtD
Nefazodone—Dyspepsia—Betamethasone—asthma	3.25e-05	0.000125	CcSEcCtD
Nefazodone—Dyspepsia—Dexamethasone—asthma	3.25e-05	0.000125	CcSEcCtD
Nefazodone—Urticaria—Triamcinolone—asthma	3.24e-05	0.000125	CcSEcCtD
Nefazodone—Urticaria—Methylprednisolone—asthma	3.23e-05	0.000125	CcSEcCtD
Nefazodone—Body temperature increased—Triamcinolone—asthma	3.22e-05	0.000124	CcSEcCtD
Nefazodone—Oedema—Prednisone—asthma	3.22e-05	0.000124	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisone—asthma	3.22e-05	0.000124	CcSEcCtD
Nefazodone—Abdominal pain—Methylprednisolone—asthma	3.21e-05	0.000124	CcSEcCtD
Nefazodone—Decreased appetite—Dexamethasone—asthma	3.21e-05	0.000124	CcSEcCtD
Nefazodone—Decreased appetite—Betamethasone—asthma	3.21e-05	0.000124	CcSEcCtD
Nefazodone—Infection—Prednisone—asthma	3.2e-05	0.000123	CcSEcCtD
Nefazodone—Hypersensitivity—Hydrocortisone—asthma	3.19e-05	0.000123	CcSEcCtD
Nefazodone—Shock—Prednisone—asthma	3.17e-05	0.000122	CcSEcCtD
Nefazodone—Pain—Dexamethasone—asthma	3.16e-05	0.000122	CcSEcCtD
Nefazodone—Pain—Betamethasone—asthma	3.16e-05	0.000122	CcSEcCtD
Nefazodone—Tachycardia—Prednisone—asthma	3.14e-05	0.000121	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisone—asthma	3.11e-05	0.00012	CcSEcCtD
Nefazodone—Asthenia—Hydrocortisone—asthma	3.11e-05	0.00012	CcSEcCtD
Nefazodone—Anorexia—Prednisone—asthma	3.07e-05	0.000118	CcSEcCtD
Nefazodone—Pruritus—Hydrocortisone—asthma	3.06e-05	0.000118	CcSEcCtD
Nefazodone—Feeling abnormal—Betamethasone—asthma	3.05e-05	0.000117	CcSEcCtD
Nefazodone—Feeling abnormal—Dexamethasone—asthma	3.05e-05	0.000117	CcSEcCtD
Nefazodone—Gastrointestinal pain—Betamethasone—asthma	3.02e-05	0.000117	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dexamethasone—asthma	3.02e-05	0.000117	CcSEcCtD
Nefazodone—Hypersensitivity—Triamcinolone—asthma	3e-05	0.000116	CcSEcCtD
Nefazodone—Hypersensitivity—Methylprednisolone—asthma	3e-05	0.000115	CcSEcCtD
Nefazodone—Diarrhoea—Hydrocortisone—asthma	2.96e-05	0.000114	CcSEcCtD
Nefazodone—Urticaria—Dexamethasone—asthma	2.94e-05	0.000113	CcSEcCtD
Nefazodone—Urticaria—Betamethasone—asthma	2.94e-05	0.000113	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Prednisone—asthma	2.93e-05	0.000113	CcSEcCtD
Nefazodone—Dizziness—Prednisolone—asthma	2.93e-05	0.000113	CcSEcCtD
Nefazodone—Asthenia—Triamcinolone—asthma	2.92e-05	0.000113	CcSEcCtD
Nefazodone—Abdominal pain—Betamethasone—asthma	2.92e-05	0.000113	CcSEcCtD
Nefazodone—Body temperature increased—Betamethasone—asthma	2.92e-05	0.000113	CcSEcCtD
Nefazodone—Abdominal pain—Dexamethasone—asthma	2.92e-05	0.000113	CcSEcCtD
Nefazodone—Body temperature increased—Dexamethasone—asthma	2.92e-05	0.000113	CcSEcCtD
Nefazodone—Asthenia—Methylprednisolone—asthma	2.92e-05	0.000112	CcSEcCtD
Nefazodone—Insomnia—Prednisone—asthma	2.91e-05	0.000112	CcSEcCtD
Nefazodone—Paraesthesia—Prednisone—asthma	2.89e-05	0.000111	CcSEcCtD
Nefazodone—Pruritus—Triamcinolone—asthma	2.88e-05	0.000111	CcSEcCtD
Nefazodone—Pruritus—Methylprednisolone—asthma	2.88e-05	0.000111	CcSEcCtD
Nefazodone—Dizziness—Hydrocortisone—asthma	2.86e-05	0.00011	CcSEcCtD
Nefazodone—Dyspepsia—Prednisone—asthma	2.83e-05	0.000109	CcSEcCtD
Nefazodone—Decreased appetite—Prednisone—asthma	2.8e-05	0.000108	CcSEcCtD
Nefazodone—Rash—Prednisolone—asthma	2.79e-05	0.000108	CcSEcCtD
Nefazodone—Dermatitis—Prednisolone—asthma	2.79e-05	0.000108	CcSEcCtD
Nefazodone—Diarrhoea—Methylprednisolone—asthma	2.78e-05	0.000107	CcSEcCtD
Nefazodone—Headache—Prednisolone—asthma	2.78e-05	0.000107	CcSEcCtD
Nefazodone—Constipation—Prednisone—asthma	2.75e-05	0.000106	CcSEcCtD
Nefazodone—Vomiting—Hydrocortisone—asthma	2.75e-05	0.000106	CcSEcCtD
Nefazodone—Rash—Hydrocortisone—asthma	2.73e-05	0.000105	CcSEcCtD
Nefazodone—Dermatitis—Hydrocortisone—asthma	2.73e-05	0.000105	CcSEcCtD
Nefazodone—Headache—Hydrocortisone—asthma	2.71e-05	0.000105	CcSEcCtD
Nefazodone—Dizziness—Triamcinolone—asthma	2.69e-05	0.000104	CcSEcCtD
Nefazodone—Dizziness—Methylprednisolone—asthma	2.69e-05	0.000104	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisone—asthma	2.65e-05	0.000102	CcSEcCtD
Nefazodone—Asthenia—Betamethasone—asthma	2.65e-05	0.000102	CcSEcCtD
Nefazodone—Asthenia—Dexamethasone—asthma	2.65e-05	0.000102	CcSEcCtD
Nefazodone—Gastrointestinal pain—Prednisone—asthma	2.63e-05	0.000102	CcSEcCtD
Nefazodone—Nausea—Prednisolone—asthma	2.63e-05	0.000101	CcSEcCtD
Nefazodone—Pruritus—Betamethasone—asthma	2.62e-05	0.000101	CcSEcCtD
Nefazodone—Pruritus—Dexamethasone—asthma	2.62e-05	0.000101	CcSEcCtD
Nefazodone—Vomiting—Triamcinolone—asthma	2.59e-05	9.99e-05	CcSEcCtD
Nefazodone—Vomiting—Methylprednisolone—asthma	2.59e-05	9.97e-05	CcSEcCtD
Nefazodone—Nausea—Hydrocortisone—asthma	2.57e-05	9.91e-05	CcSEcCtD
Nefazodone—Rash—Triamcinolone—asthma	2.57e-05	9.91e-05	CcSEcCtD
Nefazodone—Dermatitis—Triamcinolone—asthma	2.57e-05	9.9e-05	CcSEcCtD
Nefazodone—Rash—Methylprednisolone—asthma	2.56e-05	9.88e-05	CcSEcCtD
Nefazodone—Dermatitis—Methylprednisolone—asthma	2.56e-05	9.87e-05	CcSEcCtD
Nefazodone—Urticaria—Prednisone—asthma	2.56e-05	9.86e-05	CcSEcCtD
Nefazodone—Headache—Triamcinolone—asthma	2.55e-05	9.84e-05	CcSEcCtD
Nefazodone—Headache—Methylprednisolone—asthma	2.55e-05	9.82e-05	CcSEcCtD
Nefazodone—Body temperature increased—Prednisone—asthma	2.55e-05	9.81e-05	CcSEcCtD
Nefazodone—Abdominal pain—Prednisone—asthma	2.55e-05	9.81e-05	CcSEcCtD
Nefazodone—Diarrhoea—Dexamethasone—asthma	2.53e-05	9.75e-05	CcSEcCtD
Nefazodone—Diarrhoea—Betamethasone—asthma	2.53e-05	9.75e-05	CcSEcCtD
Nefazodone—Dizziness—Betamethasone—asthma	2.45e-05	9.43e-05	CcSEcCtD
Nefazodone—Dizziness—Dexamethasone—asthma	2.45e-05	9.43e-05	CcSEcCtD
Nefazodone—Nausea—Triamcinolone—asthma	2.42e-05	9.33e-05	CcSEcCtD
Nefazodone—Nausea—Methylprednisolone—asthma	2.42e-05	9.31e-05	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisone—asthma	2.37e-05	9.15e-05	CcSEcCtD
Nefazodone—Vomiting—Betamethasone—asthma	2.35e-05	9.06e-05	CcSEcCtD
Nefazodone—Vomiting—Dexamethasone—asthma	2.35e-05	9.06e-05	CcSEcCtD
Nefazodone—Rash—Dexamethasone—asthma	2.33e-05	8.99e-05	CcSEcCtD
Nefazodone—Rash—Betamethasone—asthma	2.33e-05	8.99e-05	CcSEcCtD
Nefazodone—Dermatitis—Dexamethasone—asthma	2.33e-05	8.98e-05	CcSEcCtD
Nefazodone—Dermatitis—Betamethasone—asthma	2.33e-05	8.98e-05	CcSEcCtD
Nefazodone—Headache—Dexamethasone—asthma	2.32e-05	8.93e-05	CcSEcCtD
Nefazodone—Headache—Betamethasone—asthma	2.32e-05	8.93e-05	CcSEcCtD
Nefazodone—Asthenia—Prednisone—asthma	2.31e-05	8.91e-05	CcSEcCtD
Nefazodone—Pruritus—Prednisone—asthma	2.28e-05	8.78e-05	CcSEcCtD
Nefazodone—Diarrhoea—Prednisone—asthma	2.2e-05	8.49e-05	CcSEcCtD
Nefazodone—Nausea—Betamethasone—asthma	2.2e-05	8.47e-05	CcSEcCtD
Nefazodone—Nausea—Dexamethasone—asthma	2.2e-05	8.47e-05	CcSEcCtD
Nefazodone—Dizziness—Prednisone—asthma	2.13e-05	8.21e-05	CcSEcCtD
Nefazodone—Vomiting—Prednisone—asthma	2.05e-05	7.89e-05	CcSEcCtD
Nefazodone—Rash—Prednisone—asthma	2.03e-05	7.83e-05	CcSEcCtD
Nefazodone—Dermatitis—Prednisone—asthma	2.03e-05	7.82e-05	CcSEcCtD
Nefazodone—Headache—Prednisone—asthma	2.02e-05	7.78e-05	CcSEcCtD
Nefazodone—Nausea—Prednisone—asthma	1.91e-05	7.37e-05	CcSEcCtD
Nefazodone—HTR2C—Signaling Pathways—CCR5—asthma	6.73e-06	7.03e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTRK1—asthma	6.73e-06	7.02e-05	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—asthma	6.69e-06	6.98e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—RHOA—asthma	6.67e-06	6.96e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2RA—asthma	6.67e-06	6.96e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADRB2—asthma	6.66e-06	6.95e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2RA—asthma	6.63e-06	6.92e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—asthma	6.62e-06	6.91e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—C3—asthma	6.61e-06	6.9e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CXCL8—asthma	6.6e-06	6.88e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CD86—asthma	6.59e-06	6.88e-05	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CXCL8—asthma	6.59e-06	6.88e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—asthma	6.58e-06	6.87e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—C3—asthma	6.58e-06	6.87e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PPP2CA—asthma	6.56e-06	6.85e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EDN1—asthma	6.54e-06	6.82e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL5—asthma	6.49e-06	6.77e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPP2CA—asthma	6.48e-06	6.76e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PLA2G4A—asthma	6.46e-06	6.75e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CD86—asthma	6.45e-06	6.74e-05	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CXCL8—asthma	6.45e-06	6.73e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PLA2G4A—asthma	6.44e-06	6.73e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GSTM1—asthma	6.44e-06	6.73e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—asthma	6.44e-06	6.73e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PDGFB—asthma	6.44e-06	6.72e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EDN1—asthma	6.4e-06	6.68e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PDGFB—asthma	6.4e-06	6.68e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CSF2—asthma	6.39e-06	6.67e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALOX5AP—asthma	6.36e-06	6.64e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALOX15—asthma	6.36e-06	6.64e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL5—asthma	6.35e-06	6.63e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2RA—asthma	6.35e-06	6.63e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NQO1—asthma	6.35e-06	6.62e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PLA2G4A—asthma	6.33e-06	6.61e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—asthma	6.3e-06	6.58e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—POMC—asthma	6.3e-06	6.58e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—C3—asthma	6.3e-06	6.57e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ITPR1—asthma	6.3e-06	6.57e-05	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—asthma	6.3e-06	6.57e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CSF2—asthma	6.26e-06	6.53e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SMAD3—asthma	6.22e-06	6.49e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADCY2—asthma	6.21e-06	6.48e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—RHOA—asthma	6.2e-06	6.47e-05	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—asthma	6.16e-06	6.43e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LEP—asthma	6.16e-06	6.42e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PDGFB—asthma	6.13e-06	6.4e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LEP—asthma	6.12e-06	6.39e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SMAD3—asthma	6.09e-06	6.36e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CHAT—asthma	6.07e-06	6.33e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CD86—asthma	6e-06	6.26e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CXCL8—asthma	5.99e-06	6.26e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CXCL8—asthma	5.98e-06	6.24e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NQO1—asthma	5.98e-06	6.24e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PPP2CA—asthma	5.95e-06	6.21e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EDN1—asthma	5.95e-06	6.21e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPP2CA—asthma	5.94e-06	6.19e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL5—asthma	5.9e-06	6.16e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PLA2G4A—asthma	5.88e-06	6.14e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LEP—asthma	5.86e-06	6.12e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CXCL8—asthma	5.86e-06	6.11e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADCY2—asthma	5.85e-06	6.11e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—asthma	5.85e-06	6.1e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PPP2CA—asthma	5.83e-06	6.08e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CSF2—asthma	5.81e-06	6.07e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—FN1—asthma	5.81e-06	6.06e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—FN1—asthma	5.78e-06	6.03e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2RA—asthma	5.76e-06	6.01e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—asthma	5.75e-06	6e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—asthma	5.73e-06	5.98e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—asthma	5.72e-06	5.97e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—asthma	5.72e-06	5.97e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—C3—asthma	5.71e-06	5.96e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SMAD3—asthma	5.66e-06	5.91e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2RA—asthma	5.64e-06	5.89e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—asthma	5.6e-06	5.84e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—C3—asthma	5.59e-06	5.84e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PDGFB—asthma	5.56e-06	5.8e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—FN1—asthma	5.53e-06	5.77e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—NOS3—asthma	5.5e-06	5.74e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PDGFB—asthma	5.44e-06	5.68e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CXCL8—asthma	5.44e-06	5.68e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PPP2CA—asthma	5.42e-06	5.65e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALOX5—asthma	5.41e-06	5.64e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—asthma	5.32e-06	5.55e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LEP—asthma	5.32e-06	5.55e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GSTP1—asthma	5.29e-06	5.52e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—POMC—asthma	5.29e-06	5.52e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—POMC—asthma	5.26e-06	5.49e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2RA—asthma	5.24e-06	5.47e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—HMOX1—asthma	5.22e-06	5.45e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LEP—asthma	5.21e-06	5.43e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ITPR1—asthma	5.21e-06	5.43e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—asthma	5.2e-06	5.43e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—C3—asthma	5.2e-06	5.42e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL2—asthma	5.17e-06	5.4e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6R—asthma	5.16e-06	5.38e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CARM1—asthma	5.16e-06	5.38e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAT—asthma	5.15e-06	5.37e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL2—asthma	5.15e-06	5.37e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6R—asthma	5.13e-06	5.36e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—DCN—asthma	5.08e-06	5.31e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—EGFR—asthma	5.06e-06	5.28e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PDGFB—asthma	5.06e-06	5.28e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—POMC—asthma	5.04e-06	5.26e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—EGFR—asthma	5.04e-06	5.26e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—asthma	5.03e-06	5.25e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—FN1—asthma	5.02e-06	5.23e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GSTP1—asthma	4.99e-06	5.2e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—POMC—asthma	4.97e-06	5.19e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALDH2—asthma	4.95e-06	5.16e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL2—asthma	4.93e-06	5.14e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—HMOX1—asthma	4.92e-06	5.13e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6R—asthma	4.91e-06	5.13e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—FN1—asthma	4.91e-06	5.13e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ITPR1—asthma	4.91e-06	5.12e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PLA2G4A—asthma	4.86e-06	5.08e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GSTM1—asthma	4.86e-06	5.08e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAT—asthma	4.85e-06	5.06e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LEP—asthma	4.84e-06	5.05e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SERPINE1—asthma	4.83e-06	5.04e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—EGFR—asthma	4.82e-06	5.03e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SERPINE1—asthma	4.81e-06	5.02e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTT1—asthma	4.7e-06	4.91e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RHOA—asthma	4.66e-06	4.86e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RHOA—asthma	4.64e-06	4.84e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—asthma	4.61e-06	4.81e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SERPINE1—asthma	4.6e-06	4.8e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—asthma	4.59e-06	4.79e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PLA2G4A—asthma	4.58e-06	4.78e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GSTM1—asthma	4.58e-06	4.78e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—asthma	4.57e-06	4.77e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—FN1—asthma	4.56e-06	4.76e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—asthma	4.56e-06	4.75e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—asthma	4.53e-06	4.73e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPP2CA—asthma	4.48e-06	4.67e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—asthma	4.47e-06	4.67e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—asthma	4.47e-06	4.67e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6R—asthma	4.46e-06	4.65e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RHOA—asthma	4.44e-06	4.63e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—asthma	4.39e-06	4.58e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTEN—asthma	4.38e-06	4.57e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—asthma	4.38e-06	4.57e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—EGFR—asthma	4.37e-06	4.56e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6R—asthma	4.36e-06	4.55e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—asthma	4.34e-06	4.52e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—EGFR—asthma	4.28e-06	4.47e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPP2CA—asthma	4.22e-06	4.4e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SERPINE1—asthma	4.17e-06	4.36e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—asthma	4.16e-06	4.34e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—asthma	4.15e-06	4.33e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL8—asthma	4.09e-06	4.27e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SERPINE1—asthma	4.09e-06	4.26e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL8—asthma	4.07e-06	4.25e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—asthma	4.07e-06	4.24e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6R—asthma	4.05e-06	4.23e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RHOA—asthma	4.03e-06	4.2e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—asthma	3.98e-06	4.16e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—EGFR—asthma	3.98e-06	4.15e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—asthma	3.97e-06	4.15e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—asthma	3.96e-06	4.14e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RHOA—asthma	3.94e-06	4.11e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—asthma	3.91e-06	4.08e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NQO1—asthma	3.91e-06	4.08e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—asthma	3.9e-06	4.07e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL8—asthma	3.9e-06	4.07e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—asthma	3.89e-06	4.06e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—asthma	3.89e-06	4.06e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—asthma	3.87e-06	4.04e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADCY2—asthma	3.83e-06	3.99e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SERPINE1—asthma	3.8e-06	3.96e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—asthma	3.72e-06	3.89e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—asthma	3.7e-06	3.87e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MMP9—asthma	3.7e-06	3.86e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MMP9—asthma	3.68e-06	3.84e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PTEN—asthma	3.68e-06	3.84e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RHOA—asthma	3.66e-06	3.82e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PTEN—asthma	3.66e-06	3.82e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—asthma	3.63e-06	3.79e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—asthma	3.62e-06	3.78e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL8—asthma	3.53e-06	3.69e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP9—asthma	3.52e-06	3.68e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PTEN—asthma	3.5e-06	3.66e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL8—asthma	3.46e-06	3.61e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTEN—asthma	3.46e-06	3.61e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—asthma	3.44e-06	3.59e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—asthma	3.38e-06	3.52e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—asthma	3.36e-06	3.51e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VEGFA—asthma	3.32e-06	3.47e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—asthma	3.31e-06	3.45e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VEGFA—asthma	3.31e-06	3.45e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—asthma	3.29e-06	3.43e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—STAT3—asthma	3.29e-06	3.43e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—STAT3—asthma	3.27e-06	3.42e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTP1—asthma	3.26e-06	3.4e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—asthma	3.24e-06	3.38e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HMOX1—asthma	3.22e-06	3.36e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL8—asthma	3.22e-06	3.36e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ITPR1—asthma	3.21e-06	3.35e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP9—asthma	3.2e-06	3.34e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PTEN—asthma	3.18e-06	3.32e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAT—asthma	3.17e-06	3.31e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTEN—asthma	3.17e-06	3.31e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VEGFA—asthma	3.16e-06	3.3e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—asthma	3.13e-06	3.27e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—STAT3—asthma	3.13e-06	3.27e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP9—asthma	3.13e-06	3.27e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PTEN—asthma	3.11e-06	3.25e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—asthma	3.07e-06	3.21e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—asthma	3.06e-06	3.19e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—asthma	3.05e-06	3.18e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—asthma	3.03e-06	3.17e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—asthma	3e-06	3.13e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PLA2G4A—asthma	3e-06	3.13e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTM1—asthma	3e-06	3.13e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EGFR—asthma	2.99e-06	3.12e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EGFR—asthma	2.97e-06	3.1e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—asthma	2.95e-06	3.08e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP9—asthma	2.91e-06	3.04e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—asthma	2.9e-06	3.03e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PTEN—asthma	2.89e-06	3.02e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VEGFA—asthma	2.87e-06	3e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EGFR—asthma	2.85e-06	2.97e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—STAT3—asthma	2.84e-06	2.97e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—asthma	2.82e-06	2.95e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VEGFA—asthma	2.81e-06	2.93e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—STAT3—asthma	2.78e-06	2.9e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPP2CA—asthma	2.76e-06	2.88e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—asthma	2.74e-06	2.86e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—asthma	2.63e-06	2.75e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VEGFA—asthma	2.61e-06	2.73e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—STAT3—asthma	2.59e-06	2.7e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—asthma	2.58e-06	2.7e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EGFR—asthma	2.58e-06	2.7e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—asthma	2.58e-06	2.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EGFR—asthma	2.53e-06	2.64e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—asthma	2.4e-06	2.5e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTEN—asthma	2.39e-06	2.5e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EGFR—asthma	2.35e-06	2.45e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—asthma	2.3e-06	2.4e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—asthma	2.29e-06	2.39e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTEN—asthma	2.25e-06	2.35e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—asthma	2.19e-06	2.28e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—asthma	2.12e-06	2.21e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—asthma	1.99e-06	2.07e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—asthma	1.94e-06	2.03e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—asthma	1.93e-06	2.02e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—asthma	1.85e-06	1.93e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—asthma	1.81e-06	1.88e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—asthma	1.69e-06	1.76e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTEN—asthma	1.47e-06	1.54e-05	CbGpPWpGaD
